Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Activity of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring rare epidermal growth factor receptor mutations.
De Pas T, Toffalorio F, Manzotti M, Fumagalli C, Spitaleri G, Catania C, Delmonte A, Giovannini M, Spaggiari L, de Braud F, Barberis M. De Pas T, et al. Among authors: fumagalli c. J Thorac Oncol. 2011 Nov;6(11):1895-901. doi: 10.1097/JTO.0b013e318227e8c6. J Thorac Oncol. 2011. PMID: 21841502 Free article.
Phase ib of sorafenib in combination with everolimus in patients with advanced solid tumors, selected on the basis of molecular targets.
Toffalorio F, Spitaleri G, Catania C, Dal Zotto L, Noberasco C, Delmonte A, Santarpia M, Vecchio F, Brunelli V, Rampinelli C, Barberis M, Fumagalli C, Zucchetti M, Zangarini M, Diena T, Danesi R, de Braud F, De Pas T. Toffalorio F, et al. Among authors: fumagalli c. Oncologist. 2014 Apr;19(4):344-5. doi: 10.1634/theoncologist.2013-0335. Epub 2014 Mar 27. Oncologist. 2014. PMID: 24674875 Free PMC article. Clinical Trial.
Prevalence and clinicopathologic correlates of O⁶-methylguanine-DNA methyltransferase methylation status in patients with triple-negative breast cancer treated preoperatively by alkylating drugs.
Fumagalli C, Della Pasqua S, Bagnardi V, Cardillo A, Sporchia A, Colleoni M, Viale G, Barberis M, Pruneri G. Fumagalli C, et al. Clin Breast Cancer. 2014 Aug;14(4):285-90. doi: 10.1016/j.clbc.2014.02.010. Epub 2014 Mar 2. Clin Breast Cancer. 2014. PMID: 24709436
Letter to the Editor.
Fumagalli C, Casadio C, Barberis M, Guarize J, Guerini-Rocco E. Fumagalli C, et al. Clin Lung Cancer. 2018 Jul;19(4):e439-e440. doi: 10.1016/j.cllc.2018.03.001. Epub 2018 Mar 12. Clin Lung Cancer. 2018. PMID: 29606366 Free article. No abstract available.
Temozolomide alone or in combination with capecitabine in patients with advanced neuroendocrine neoplasms: an Italian multicenter real-world analysis.
Spada F, Maisonneuve P, Fumagalli C, Marconcini R, Gelsomino F, Antonuzzo L, Campana D, Puliafito I, Rossi G, Faviana P, Messerini L, Barberis M, Fazio N. Spada F, et al. Among authors: fumagalli c. Endocrine. 2021 Apr;72(1):268-278. doi: 10.1007/s12020-020-02421-2. Epub 2020 Jul 22. Endocrine. 2021. PMID: 32700133
203 results